Keywords: Pfizer, Strategic options, Animal Health, Nutrition, Divestment

Pfizer confirms it is viewing options, including sale, of its Animal Health and Nutrition businesses

Article | 08 July 2011

Print This

Global drugs behemoth Pfizer (NYSE: PFE), which is facing patent loss on the biggest ever-selling drug, its cholesterol lowerer Lipitor ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in